These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 6862293

  • 1. Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study.
    Stehman FB, Blom J, Blessing JA, Ehrlich CE, Mangan C.
    Gynecol Oncol; 1983 Jun; 15(3):381-90. PubMed ID: 6862293
    [Abstract] [Full Text] [Related]

  • 2. Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group study.
    Stehman FB, Blessing JA, Homesley HD, Currie JL, Yordan EL.
    Invest New Drugs; 1984 Jun; 2(3):331-3. PubMed ID: 6511240
    [Abstract] [Full Text] [Related]

  • 3. Dianhydrogalactitol and cisplatin in combination for advanced cancer of the uterine cervix.
    Vogl SE, Seltzer V, Camacho F, Calanog A.
    Cancer Treat Rep; 1982 Oct; 66(10):1809-12. PubMed ID: 6889913
    [Abstract] [Full Text] [Related]

  • 4. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
    Haas CD, Baker L, Thigpen T.
    Cancer Treat Rep; 1981 Oct; 65(1-2):115-7. PubMed ID: 6261943
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group.
    Thigpen T, Shingleton H, Homesley H, LaGasse L, Blessing J.
    Cancer Treat Rep; 1979 Oct; 63(9-10):1549-55. PubMed ID: 498154
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study.
    Thigpen JT, Al-Sarraf M, Hewlett JS.
    Cancer Treat Rep; 1979 Apr; 63(4):525-8. PubMed ID: 445506
    [Abstract] [Full Text] [Related]

  • 10. Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
    de Jager R, Brugarolas A, Hansen H, Cavalli F, Ryssel H, Siegenthaler P, Clarysse A, Renard J, Kenis Y, Alberto P.
    Eur J Cancer (1965); 1979 Jul; 15(7):971-4. PubMed ID: 385328
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
    Ratanatharathorn V, Baker LH, Balducci L, Talley RW, Hoogstraten B.
    Cancer Treat Rep; 1982 May; 66(5):1231-2. PubMed ID: 7083224
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
    Muss HB, Blessing JA, Eddy GL, McGehee R.
    Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.